News | January 21, 2025
Moderna announces updates on pandemic influenza program
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
The project will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.
Subscribe To Our Newsletter & Stay Updated
